ethoxzolamide has been researched along with Injury, Myocardial Reperfusion in 1 studies
Ethoxzolamide: A carbonic anhydrase inhibitor used as diuretic and in glaucoma. It may cause hypokalemia.
ethoxzolamide : A sulfonamide that is 1,3-benzothiazole-2-sulfonamide which is substituted by an ethoxy group at position 6. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciocci Pardo, A | 1 |
| González Arbeláez, LF | 1 |
| Fantinelli, JC | 1 |
| Álvarez, BV | 1 |
| Mosca, SM | 1 |
| Swenson, ER | 1 |
1 other study available for ethoxzolamide and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Myocardial and mitochondrial effects of the anhydrase carbonic inhibitor ethoxzolamide in ischemia-reperfusion.
Topics: Animals; Benzophenanthridines; Calcium; Carbonic Anhydrase Inhibitors; Enzyme Inhibitors; Ethoxzolam | 2021 |